Market analytics and operational performance indicators
Rocket Lab SEC Filings
Browse Rocket Lab filings, review key metrics, and open source documents from one place.
SEC Command Deck
Use this feed to separate quarterly and annual operating disclosures from one-off event filings and insider ownership changes before opening full analysis or source documents.
What matters now
Latest Filings
Read the brief first, then open the full filing only when you need document-level detail.
This Form SD is a specialized disclosure regarding the company's conflict minerals inquiry for the period of January 1 to December 31, 2025. It confirms that Rocket Lab conducted a reasonable country of origin inquiry (RCOI) regarding minerals used in its products. The filing is a routine regulatory requirement to ensure supply chain transparency.
This Form 144 filing is a notice of proposed sale of securities by Alexander R. Slusky, a Director of Rocket Lab Corp. The filing details the intent to sell 100,000 shares of common stock on the NASDAQ exchange. This is a routine disclosure of planned divestment by an insider.
Marvin Bradford Clevenger, President of Rocket Lab USA, Inc., executed several sales of common stock. These transactions were non-discretionary 'sell-to-cover' sales intended to satisfy tax withholding obligations related to the vesting of restricted stock units. The signal is neutral.
SVP & General Counsel Arjun Kampani executed multiple sales of common stock totaling 99,768 shares. The signal is neutral as the transactions were automatic 'sell-to-cover' sales for tax obligations under a 10b5-1 plan.
COO Frank Klein sold 44,390 shares ($6.33M) via 10b5-1 sell-to-cover plan. The signal is neutral.
CEO Peter Beck converted 5,000,000 shares of Series A Preferred Stock into Common Stock. This transaction is neutral as the conversion was performed to facilitate future sales under a pre-existing 10b5-1 trading plan.
CFO Adam Spice sold 62,744 shares ($8.96M) via Rule 10b5-1 sell-to-cover transactions. This is a neutral signal as the sales were to satisfy tax withholding obligations related to RSU vesting.
This Form 144 filing notifies the SEC of a proposed sale of common stock by Marvin Bradford Clevenger, an officer of Rocket Lab Corporation. The notice outlines the intent to sell shares through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. This filing is a standard regulatory requirement for insiders planning to sell securities.
This Form 144 notice discloses a proposed sale of 36,860 shares of common stock by Frank Klein, an Officer of Rocket Lab Corporation. The sale is being executed through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $5,537,477.80. This filing is relevant to investors monitoring insider trading activity and liquidity.
This Form 144 notice discloses a proposed sale of 23,804 shares of Rocket Lab common stock by Arjun Kampani, an officer of the company. The sale is being executed via Morgan Stanley Smith Barney LLC on the NASDAQ. This filing is part of a pre-established 10b5-1 trading plan.
Rocket Lab files annual Conflict Minerals Report for the 2025 reporting period.
Key Telemetry
- • Reporting period covered: January 1, 2025, to December 31, 2025.
- • Company conducted a reasonable country of origin inquiry (RCOI) as required by Rule 13p-1.
Director Alexander R. Slusky proposes selling 100,000 shares of common stock.
Key Telemetry
- • Proposed sale of 100,000 shares of common stock by Director Alexander R. Slusky.
- • Aggregate market value of the proposed sale is $14,803,000.
President Clevenger sold 15,557 shares (~$2.2M) via sell-to-cover tax withholding transactions.
Key Telemetry
- • Total shares sold: 15,557 across six transaction blocks.
- • Transaction purpose: 'Sell-to-cover' for tax withholding obligations due to RSU vesting.
SVP Kampani sold 99,768 shares (~$14.4M) via 10b5-1 tax withholding sales
Key Telemetry
- • Total shares sold: 99,768 shares across 8 transaction tranches
- • Transactions were part of a Rule 10b5-1 plan to cover tax obligations for RSU vesting
COO Klein sold 44,390 shares ($6.33M) via 10b5-1 sell-to-cover tax plan(s).
Key Telemetry
- • Total sale of 44,390 shares across six tranches totaling approximately $6.33M
- • Transaction was executed via a Rule 10b5-1 plan for 'sell-to-cover' tax obligations
CEO Beck converted 5,000,000 preferred shares into common stock via 10b5-1 plan.
Key Telemetry
- • Conversion of 5,000,000 Series A Preferred shares into Common Stock
- • Transaction executed pursuant to a Rule 10b5-1 plan adopted on March 27, 2026
CFO Spice sold 62,744 shares ($8.96M) via Rule 10b5-1 sell-to-cover tax obligation sales.
Key Telemetry
- • Sold a total of 62,744 shares across multiple tranches on 05/26/2026
- • Transaction was a 'sell-to-cover' pursuant to a Rule 10b5-1 plan to satisfy tax obligations
Executive Marvin Bradford Clevenger proposes selling 3,500 shares of Rocket Lab common stock.
Key Telemetry
- • Filer Marvin Bradford Clevenger (Officer) proposes to sell 3,500 shares of common stock.
- • The approximate aggregate market value of the proposed sale is $513,355.85.
Officer Frank Klein proposes selling 36,860 shares of Rocket Lab Common stock.
Key Telemetry
- • Proposed sale of 36,860 shares of Common stock by Officer Frank Klein.
- • Estimated aggregate market value of the proposed sale is $5,537,477.80.
Executive Arjun Kampani files notice to sell 23,804 common shares.
Key Telemetry
- • Proposed sale of 23,804 common shares by officer Arjun Kampani.
- • Aggregate market value of the proposed sale is approximately $3,576,074.92.